These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: A historical review. Wilcox SR J Crit Care; 2017 Feb; 37():149-155. PubMed ID: 27736708 [TBL] [Abstract][Full Text] [Related]
7. Functional recovery after neuromuscular blockade in mechanically ventilated critically ill patients. Whetstone Foster JG; Clark AP Heart Lung; 2006; 35(3):178-89. PubMed ID: 16701112 [TBL] [Abstract][Full Text] [Related]
8. Association between neuromuscular blocking agents and the development of intensive care unit-acquired weakness (ICU-AW): A systematic review with meta-analysis and trial sequential analysis. Bellaver P; Schaeffer AF; Leitao CB; Rech TH; Nedel WL Anaesth Crit Care Pain Med; 2023 Jun; 42(3):101202. PubMed ID: 36804373 [TBL] [Abstract][Full Text] [Related]
9. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient. deBacker J; Hart N; Fan E Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334 [TBL] [Abstract][Full Text] [Related]
10. Intensive care unit-acquired weakness: unanswered questions and targets for future research. Piva S; Fagoni N; Latronico N F1000Res; 2019; 8():. PubMed ID: 31069055 [TBL] [Abstract][Full Text] [Related]
11. Train-of-four results and observed muscle movement in children during continuous neuromuscular blockade. Corso L Crit Care Nurse; 2008 Jun; 28(3):30-8; quiz 39. PubMed ID: 18515606 [No Abstract] [Full Text] [Related]
12. A review of neuromuscular blockade in the critically ill patient. Burry L; HoSang M; Hynes-Gay P Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205 [TBL] [Abstract][Full Text] [Related]
15. [Current status for animal models of intensive care unit acquired muscle weakness]. Zou W; Liu F; Li J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 43(6):691-696. PubMed ID: 30110014 [TBL] [Abstract][Full Text] [Related]
16. Sedation and neuromuscular blockade in patients with acute respiratory failure. Luer JM Crit Care Nurse; 2000 Oct; 20(5):84-9. PubMed ID: 11878492 [No Abstract] [Full Text] [Related]
17. Role of neuromuscular blocking agents in the development of polyneuropathy and myopathy in critically ill patients. Armestar F; Vitoria Rubio S; Ojanguren Sabán I; Coll-Cantí J; Perez Molto H Med Clin (Barc); 2024 Oct; 163(7):323-326. PubMed ID: 38960793 [TBL] [Abstract][Full Text] [Related]
18. Complications associated with sedative and neuromuscular blocking drugs in critically ill patients. Prielipp RC; Coursin DB; Wood KE; Murray MJ Crit Care Clin; 1995 Oct; 11(4):983-1003. PubMed ID: 8535989 [TBL] [Abstract][Full Text] [Related]